SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.0001000+899.9%Aug 15 3:35 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Todd D. Wiener who wrote (558)8/13/1997 2:10:00 PM
From: Graham Marshman   of 1359
 
I haven't been able to find AHPs Q1 Redux sales numbers - still looking. Thought the following quote was interesting though:

7/9: "Experts say the possibility of an entirely new side effect would almost certainly reduce the sales growth of Redux and other diet drugs. "Without a
doubt, this will have a further dampening effect on sales" of Redux, says analyst Hemant Shah. "It creates a cloud over the whole diet-drug
business." He predicts that Redux sales will peak at around $200 million this year, held down by negative publicity about side effects and new
competition; previously, many analysts had predicted the drug could become a billion-dollar blockbuster."

Again, we need the conversion,

Graham
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News